Farshid Dayyani, MD

Trials

Studies that name Farshid Dayyani, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:39 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT05733689 · Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

  University of California, Irvine · recruiting · Gastroesophageal Adenocarcinoma · principal investigator
• Ph1
  NCT04920032 · Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

  University of California, Irvine · recruiting · Colon Adenocarcinoma, Colorectal Cancer · principal investigator
• Ph1
  NCT04868773 · Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy

  University of California, Irvine · completed · Colorectal Cancer, Colorectal Carcinoma, Metastatic Cancer · principal investigator
• Ph2
  NCT04472767 · Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

  University of California, Irvine · recruiting · Hepatocellular Carcinoma, HCC · principal investigator
• Ph2
  NCT04164979 · Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

  University of California, Irvine · completed · Gastric Adenocarcinoma, GastroEsophageal Cancer · principal investigator
• Ph1
  NCT04074343 · TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma

  University of California, Irvine · completed · Gastric Adenocarcinoma, GastroEsophageal Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.